A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Item 1. Business. Endexx ® © Through Hyla, our recently acquired majority-owned subsidiary, we produce and sell organic, plant-based, all-natural, zero-nicotine, tobacco-free vape products under the Hyla brand. Each “ HYLA device” contains a natural guarana extract that is blended with proprietary botanical formulas. Hyla launched its products in October 2021 and its initial inventory (140,000 devices) was sold out the following month. Hyla’s products bear the Underwriters Laboratories global safety certification and are CE approved. Through CBD Unlimited, we develop hemp-derived, cannabidiol-enhanced products, each formulated to address key segments of the health and wellness market. Through our subsidiaries and strategic partnerships, we sell high-end, full-spectrum oils, extracts, topicals, and pet products, all with the shared purpose of supporting the potential of relief of pain and inflammation for humans and pets through our e-commerce site www. cbdunlimited.
| Metric | TTM | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|
| Revenue | 4.6M | - | - | - |
| Net Income | 6.9M | -4.9M | -6.8M | -9.2M |
| EPS | $0.01 | $-0.01 | $-0.01 | $-0.02 |
| Free Cash Flow | 0 | -2.1M | -3.7M | -2.5M |
| ROIC | -91.2% | -29.5% | -241.1% | - |
| Gross Margin | 28.6% | - | - | - |
| Debt/Equity | 0.00 | -2.10 | -0.12 | - |
| Dividends/Share | $0.00 | - | - | - |
| Operating Income | -3.6M | -3.9M | -5.4M | -3.7M |
| Operating Margin | -78.7% | - | - | - |
| ROE | 0.0% | - | - | - |
| Shares Outstanding | 506M | 488M | 681M | 458M |
| Metric | 2020 | |||
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | N/A | N/A | N/A | 4.6M |
| Gross Margin | N/A | N/A | N/A | 28.6% |
| R&D | 15K | 10K | 27K | 11K |
| SG&A | 996K | 860K | 1.6M | 1.8M |
| EBIT | -3.7M | -5.4M | -3.9M | -3.6M |
| Op. Margin | N/A | N/A | N/A | -78.7% |
| Net Income | -9.2M | -6.8M | -4.9M | 6.9M |
| Net Margin | N/A | N/A | N/A | 148.6% |
| Non-Recurring | 151K | 406K | 852K | -424K |
| Returns on Capital | ||||
| ROIC | N/A | N/M | -29.5% | -91.2% |
| ROE | N/A | N/A | N/A | 0.0% |
| ROA | N/A | -386.8% | -65.0% | 56.6% |
| Cash Flow | ||||
| Op. Cash Flow | -2.5M | -3.7M | -2.1M | -2.0M |
| Free Cash Flow | -2.5M | -3.7M | -2.1M | 0 |
| Owner Earnings | -3.7M | -4.5M | -2.6M | -2.0M |
| CapEx | 0 | 0 | 0 | 0 |
| Maint. CapEx | 15K | 20K | 21K | 11K |
| Growth CapEx | N/A | N/A | N/A | 0 |
| D&A | 15K | 20K | 21K | 11K |
| CapEx/OCF | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||
| Dividends Paid | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | N/A | 0.0% |
| Stock-Based Comp | 1.2M | 721K | 456K | 55K |
| Debt Repayment | 200K | 200K | 0 | 0 |
| Balance Sheet | ||||
| Net Debt | N/A | 1.2M | 24M | 18M |
| Cash & Equiv. | N/A | 0 | 157K | 24K |
| Long-Term Debt | N/A | N/A | 19M | 761K |
| Debt/Equity | N/A | -0.12 | -2.10 | 0.00 |
| Interest Coverage | -1.2 | -5.7 | -3.2 | -3.2 |
| Equity | N/A | -10.0M | -11M | -15M |
| Total Assets | N/A | 1.8M | 13M | 12M |
| Total Liabilities | N/A | 12M | 25M | 26M |
| Intangibles | N/A | 16K | N/A | 16K |
| Retained Earnings | N/A | -40M | -44M | -48M |
| Working Capital | N/A | -10M | -15M | -23M |
| Current Assets | N/A | 1.0M | 3.4M | 2.3M |
| Current Liabilities | N/A | 11M | 18M | 25M |
| Per Share Data | ||||
| EPS | -0.02 | -0.01 | -0.01 | 0.01 |
| Owner EPS | -0.01 | -0.01 | -0.01 | -0.00 |
| Book Value | N/A | -0.01 | -0.02 | -0.03 |
| Cash Flow/Share | -0.01 | -0.01 | -0.00 | 0.01 |
| Dividends/Share | N/A | N/A | N/A | 0.00 |
| Shares Out. | 458.2M | 680.8M | 488.4M | 506.4M |
| Valuation | ||||
| P/E Ratio | N/A | N/A | N/A | 0.0 |
| P/FCF | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | N/A |
| Price/Sales | N/A | N/A | N/A | 0.0 |
| FCF Yield | N/A | N/A | -5.5% | N/A |
| Market Cap | 0 | 0 | 38M | 51K |
| Avg. Price | 0.00 | 0.00 | 0.04 | 0.00 |
| Year-End Price | 0.00 | 0.00 | 0.07 | 0.00 |
Endexx Corp passes 0 of 9 quality checks, indicating weak fundamentals.
Endexx Corp (EDXC) has a 5-year average return on invested capital (ROIC) of -29.5%. This is below average and may indicate limited pricing power.
Endexx Corp (EDXC) has a market capitalization of $51K. It is classified as a small-cap stock.
Endexx Corp (EDXC) does not currently pay a regular dividend.
Endexx Corp (EDXC) operates in the Services-Business Services, Nec industry, within the Industrials sector.
Endexx Corp (EDXC) generated $-2 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Endexx Corp (EDXC) reported earnings per share (EPS) of $-0.01 in its most recent fiscal year.
The Ledger Terminal provides 3 years of financial data for Endexx Corp (EDXC), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Endexx Corp (EDXC) has a book value per share of $-0.02, based on its most recent annual SEC filing.
No recent press releases.